Maynard Um
-
-
-
-
-
-
-
Amphastar Pharma (AMPH) Misses Q1 EPS by 30c
-
-
-
-
-
-
-
Amphastar Pharma (AMPH) Misses Q4 EPS by 20c
-
-
-
-
-
-
-
Amphastar receives FDA approval for generic teriparatide injection
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
-
-
-
-
-
-
-
Amphastar Pharma (AMPH) Tops Q2 EPS by 11c
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
-
418,486 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

